1-(2-Chlorophenyl)-1H-imidazole-4-carboxylic acid
|
- $274 - $548
- Product name: 1-(2-Chlorophenyl)-1H-imidazole-4-carboxylic acid
- CAS: 1249600-37-0
- MF: C10H7ClN2O2
- MW: 222.63
- EINECS:
- MDL Number:MFCD16666922
- Synonyms:1-(2-Chlorophenyl)-1H-imidazole-4-carboxylic acid;1H-Imidazole-4-carboxylic acid, 1-(2-chlorophenyl)-
4 prices
Selected condition:
Brand
- aablocks
- Chemenu
- Crysdot
Package
- 100mg
- 250mg
- 1g
- Manufactureraablocks
- Product numberAA01ER6G
- Product description1-(2-Chlorophenyl)-1h-imidazole-4-carboxylic acid 98%
- Packaging100mg
- Price$274
- Updated2026-05-30
- Buy
- Manufactureraablocks
- Product numberAA01ER6G
- Product description1-(2-Chlorophenyl)-1h-imidazole-4-carboxylic acid 98%
- Packaging250mg
- Price$540
- Updated2026-05-30
- Buy
- ManufacturerChemenu
- Product numberCM411110
- Product description1-(2-chlorophenyl)-1H-imidazole-4-carboxylic acid 95%+
- Packaging1g
- Price$547
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11316167
- Product description1-(2-Chlorophenyl)-1H-imidazole-4-carboxylic acid 97%
- Packaging1g
- Price$548
- Updated2026-05-27
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01ER6G | 1-(2-Chlorophenyl)-1h-imidazole-4-carboxylic acid 98% | 100mg | $274 | 2026-05-30 | Buy |
| aablocks | AA01ER6G | 1-(2-Chlorophenyl)-1h-imidazole-4-carboxylic acid 98% | 250mg | $540 | 2026-05-30 | Buy |
| Chemenu | CM411110 | 1-(2-chlorophenyl)-1H-imidazole-4-carboxylic acid 95%+ | 1g | $547 | 2026-05-26 | Buy |
| Crysdot | CD11316167 | 1-(2-Chlorophenyl)-1H-imidazole-4-carboxylic acid 97% | 1g | $548 | 2026-05-27 | Buy |
Properties
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




